United States Biotechnology & Medical Research

Savient Pharmaceuticals Inc (SVNTQ)

Track

Ticker: SVNTQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
THOMPSON VIRGIL Non-Executive Director
Transaction date
Sale
Price
356.12
Quantity 92,345 +26.5%
Value US$620,893
JAEGER STEPHEN O Non-Executive Director
Transaction date
Sale
Price
122.62
Quantity 93,981 -4.8%
Value US$1,985,181
Constantine Ginger Non-Executive Director
Transaction date
Sale
Price
392.57
Quantity 82,005 -36.7%
Value US$1,752,075
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.07
Quantity 500 -0.5%
Value US$36
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.07
Quantity 2,400 -2.3%
Value US$176
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.07
Quantity 3,500 -3.3%
Value US$261
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.07
Quantity 1,600 -1.5%
Value US$116
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.08
Quantity 3,911 -3.5%
Value US$322
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.08
Quantity 661 -0.6%
Value US$54
Gionco David Chief Accounting Officer Officer
Transaction date
Sale
Price
0.08
Quantity 10,000 -21.9%
Value US$810
Gionco David Chief Accounting Officer Officer
Transaction date
Sale
Price
0.08
Quantity 20,900 -31.4%
Value US$1,682
Gionco David Chief Accounting Officer Officer
Transaction date
Sale
Price
0.08
Quantity 3,000 -4.3%
Value US$241
Gionco David Chief Accounting Officer Officer
Transaction date
Sale
Price
0.08
Quantity 8,500 -10.9%
Value US$683
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.09
Quantity 10,000 -9.9%
Value US$916
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.10
Quantity 53,411 -34.7%
Value US$5,245
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.10
Quantity 50,000 -24.5%
Value US$4,895
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.10
Quantity 40,000 -16.4%
Value US$4,000
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.09
Quantity 20,000 -7.6%
Value US$1,828
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.10
Quantity 19,745 -7.0%
Value US$1,921
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 7,646 -10.3%
Value US$612
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 800 -1.1%
Value US$64
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 1,000 -1.3%
Value US$80
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 21,000 -21.6%
Value US$1,670
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 5,000 -4.9%
Value US$396
CROWLEY Richard Co-President and COO Officer
Transaction date
Sale
Price
0.08
Quantity 102,575 -37.4%
Value US$7,796
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.08
Quantity 65,639 -36.8%
Value US$5,336
Gionco David Chief Accounting Officer Officer
Transaction date
Sale
Price
0.08
Quantity 5,476 -6.5%
Value US$439
YACHMETZ PHILIP K Co-President and CBO Officer
Transaction date
Sale
Price
0.10
Quantity 20,000 -6.6%
Value US$2,030
Hamill John Co-President and CFO Officer
Transaction date
Sale
Price
0.08
Quantity 1,500 -1.4%
Value US$118
CROWLEY Richard Co-President and COO Officer
Transaction date
Sale
Price
0.08
Quantity 11,165 -3.9%
Value US$843
FERRARI LOUIS SVP, North American Commerical Officer
Transaction date
Purchase
Price
2.29
Quantity 4,000 +10.0%
Value US$9,160
CROWLEY Richard EVP Biopharmaceutical Operatio Officer
Transaction date
Purchase
Price
2.53
Quantity 3,000 +3.0%
Value US$7,590
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
2.30
Quantity 5,000 +1.9%
Value US$11,500
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
2.28
Quantity 10,000 +3.9%
Value US$22,800
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
2.36
Quantity 1,000 +33.3%
Value US$2,360
ZUERBLIS KENNETH J EVP, Chief Financial Officer Officer
Transaction date
Purchase
Price
2.35
Quantity 2,000 +40.0%
Value US$4,690
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Purchase
Price
2.59
Quantity 5,000 +9.4%
Value US$12,945
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
4.09
Quantity 1,500 +100.0%
Value US$6,135
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
4.10
Quantity 25,000 +10.9%
Value US$102,492
YACHMETZ PHILIP K SVP, General Counsel Officer
Transaction date
Purchase
Price
4.13
Quantity 7,000 +3.8%
Value US$28,910
ZUERBLIS KENNETH J EVP, Chief Financial Officer Officer
Transaction date
Purchase
Price
4.05
Quantity 4,000 +400.0%
Value US$16,190
HELLER ALAN L Non-Executive Director
Transaction date
Purchase
Price
3.99
Quantity 7,500 +23.0%
Value US$29,925
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Purchase
Price
3.97
Quantity 500 +1.0%
Value US$1,983
Bahrt Kenneth SVP, Chief Medical Officer Officer
Transaction date
Purchase
Price
3.95
Quantity 2,500 +5.0%
Value US$9,871
ZUERBLIS KENNETH J EVP, Chief Financial Officer Officer
Transaction date
Purchase
Price
3.97
Quantity 1,000 +inf%
Value US$3,970
JOHNSON JOHN CEO & President Executive Director
Transaction date
Purchase
Price
3.88
Quantity 1,500 +inf%
Value US$5,824
Gionco David Group VP, CFO Officer
Transaction date
Sale
Price
15.95
Quantity 7,500 -17.3%
Value US$119,625
YACHMETZ PHILIP K SVP, General Counsel Officer
Transaction date
Sale
Price
16.25
Quantity 3,750 -2.1%
Value US$60,938
Gionco David Group VP, CFO Officer
Transaction date
Sale
Price
15.36
Quantity 10,887 -23.3%
Value US$167,224
YACHMETZ PHILIP K SVP, General Counsel Officer
Transaction date
Sale
Price
15.75
Quantity 3,750 -2.0%
Value US$59,062
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Planned sale
Price
25.25
Quantity 1,231 -3.1%
Value US$31,083
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Sale
Price
25.75
Quantity 5,000 -11.2%
Value US$128,751
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Sale
Price
24.89
Quantity 1,928 -4.6%
Value US$47,994
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
26.47
Quantity 4,000 -38.4%
Value US$105,880
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
24.07
Quantity 4,000 -27.7%
Value US$96,280
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
22.67
Quantity 4,000 -21.7%
Value US$90,680
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
24.59
Quantity 4,000 -19.2%
Value US$98,360
HAYDEN BRIAN J SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
24.00
Quantity 5,000 -25.1%
Value US$120,000
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
24.35
Quantity 5,000 -23.9%
Value US$121,752
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
23.90
Quantity 4,000 -16.1%
Value US$95,600
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
23.48
Quantity 5,000 -23.9%
Value US$117,423
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Sale
Price
23.17
Quantity 4,750 -10.7%
Value US$110,077
HAYDEN BRIAN J SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
24.00
Quantity 5,000 -20.1%
Value US$120,000
KLEIN JOSEPH III Non-Executive Director
Transaction date
Sale
Price
21.71
Quantity 4,000 -13.9%
Value US$86,840
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
21.11
Quantity 5,000 -23.9%
Value US$105,572
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
21.89
Quantity 5,000 -23.9%
Value US$109,448
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
23.00
Quantity 5,000 -16.2%
Value US$115,000
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Sale
Price
22.78
Quantity 2,375 -5.7%
Value US$54,102
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
22.78
Quantity 5,000 -16.2%
Value US$113,900
HAYDEN BRIAN J SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
24.00
Quantity 2,279 -11.9%
Value US$54,696
HAYDEN BRIAN J SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
24.06
Quantity 5,000 -20.8%
Value US$120,295
HOROWITZ ZEBULUN D SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
19.86
Quantity 5,000 -3.6%
Value US$99,306
CONRAD HERBERT J Non-Executive Director
Transaction date
Sale
Price
20.00
Quantity 5,000 -16.2%
Value US$100,000
HOROWITZ ZEBULUN D SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
19.56
Quantity 5,000 -3.6%
Value US$97,791
Hamelin Paul SVP, Commercial Operations Officer
Transaction date
Sale
Price
20.00
Quantity 2,375 -5.4%
Value US$47,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-12-05 2013-12-04 S Sale THOMPSON VIRGIL Non-Executive Director
92,345 +26.5%
356.12
US$620,893 		92,345 +26.5% 356.12 US$620,893
2013-10-18 2013-10-17 S Sale JAEGER STEPHEN O Non-Executive Director
93,981 -4.8%
122.62
US$1,985,181 		93,981 -4.8% 122.62 US$1,985,181
2013-10-21 2013-10-16 S Sale Constantine Ginger Non-Executive Director
82,005 -36.7%
392.57
US$1,752,075 		82,005 -36.7% 392.57 US$1,752,075
2013-10-17 2013-10-16 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
500 -0.5%
0.07
US$36 		500 -0.5% 0.07 US$36
2013-10-17 2013-10-16 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
2,400 -2.3%
0.07
US$176 		2,400 -2.3% 0.07 US$176
2013-10-17 2013-10-16 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
3,500 -3.3%
0.07
US$261 		3,500 -3.3% 0.07 US$261
2013-10-17 2013-10-16 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
1,600 -1.5%
0.07
US$116 		1,600 -1.5% 0.07 US$116
2013-10-17 2013-10-15 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
3,911 -3.5%
0.08
US$322 		3,911 -3.5% 0.08 US$322
2013-10-17 2013-10-15 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
661 -0.6%
0.08
US$54 		661 -0.6% 0.08 US$54
2013-10-17 2013-10-15 S Sale Gionco David

Chief Accounting Officer

Officer
10,000 -21.9%
0.08
US$810 		10,000 -21.9% 0.08 US$810
2013-10-17 2013-10-15 S Sale Gionco David

Chief Accounting Officer

Officer
20,900 -31.4%
0.08
US$1,682 		20,900 -31.4% 0.08 US$1,682
2013-10-17 2013-10-15 S Sale Gionco David

Chief Accounting Officer

Officer
3,000 -4.3%
0.08
US$241 		3,000 -4.3% 0.08 US$241
2013-10-17 2013-10-15 S Sale Gionco David

Chief Accounting Officer

Officer
8,500 -10.9%
0.08
US$683 		8,500 -10.9% 0.08 US$683
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
10,000 -9.9%
0.09
US$916 		10,000 -9.9% 0.09 US$916
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
53,411 -34.7%
0.10
US$5,245 		53,411 -34.7% 0.10 US$5,245
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
50,000 -24.5%
0.10
US$4,895 		50,000 -24.5% 0.10 US$4,895
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
40,000 -16.4%
0.10
US$4,000 		40,000 -16.4% 0.10 US$4,000
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
20,000 -7.6%
0.09
US$1,828 		20,000 -7.6% 0.09 US$1,828
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
19,745 -7.0%
0.10
US$1,921 		19,745 -7.0% 0.10 US$1,921
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
7,646 -10.3%
0.08
US$612 		7,646 -10.3% 0.08 US$612
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
800 -1.1%
0.08
US$64 		800 -1.1% 0.08 US$64
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
1,000 -1.3%
0.08
US$80 		1,000 -1.3% 0.08 US$80
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
21,000 -21.6%
0.08
US$1,670 		21,000 -21.6% 0.08 US$1,670
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
5,000 -4.9%
0.08
US$396 		5,000 -4.9% 0.08 US$396
2013-10-17 2013-10-15 S Sale CROWLEY Richard

Co-President and COO

Officer
102,575 -37.4%
0.08
US$7,796 		102,575 -37.4% 0.08 US$7,796
2013-10-17 2013-10-15 S Sale Bahrt Kenneth

SVP, Chief Medical Officer

Officer
65,639 -36.8%
0.08
US$5,336 		65,639 -36.8% 0.08 US$5,336
2013-10-17 2013-10-15 S Sale Gionco David

Chief Accounting Officer

Officer
5,476 -6.5%
0.08
US$439 		5,476 -6.5% 0.08 US$439
2013-10-17 2013-10-15 S Sale YACHMETZ PHILIP K

Co-President and CBO

Officer
20,000 -6.6%
0.10
US$2,030 		20,000 -6.6% 0.10 US$2,030
2013-10-17 2013-10-15 S Sale Hamill John

Co-President and CFO

Officer
1,500 -1.4%
0.08
US$118 		1,500 -1.4% 0.08 US$118
2013-10-17 2013-10-15 S Sale CROWLEY Richard

Co-President and COO

Officer
11,165 -3.9%
0.08
US$843 		11,165 -3.9% 0.08 US$843
2011-11-22 2011-11-21 B Purchase FERRARI LOUIS

SVP, North American Commerical

Officer
4,000 +10.0%
2.29
US$9,160 		4,000 +10.0% 2.29 US$9,160
2011-11-22 2011-11-21 B Purchase CROWLEY Richard

EVP Biopharmaceutical Operatio

Officer
3,000 +3.0%
2.53
US$7,590 		3,000 +3.0% 2.53 US$7,590
2011-11-22 2011-11-21 B Purchase JOHNSON JOHN

CEO & President

Executive Director
5,000 +1.9%
2.30
US$11,500 		5,000 +1.9% 2.30 US$11,500
2011-11-21 2011-11-18 B Purchase JOHNSON JOHN

CEO & President

Executive Director
10,000 +3.9%
2.28
US$22,800 		10,000 +3.9% 2.28 US$22,800
2011-11-21 2011-11-18 B Purchase JOHNSON JOHN

CEO & President

Executive Director
1,000 +33.3%
2.36
US$2,360 		1,000 +33.3% 2.36 US$2,360
2011-11-21 2011-11-18 B Purchase ZUERBLIS KENNETH J

EVP, Chief Financial Officer

Officer
2,000 +40.0%
2.35
US$4,690 		2,000 +40.0% 2.35 US$4,690
2011-11-18 2011-11-16 B Purchase Bahrt Kenneth

SVP, Chief Medical Officer

Officer
5,000 +9.4%
2.59
US$12,945 		5,000 +9.4% 2.59 US$12,945
2011-09-16 2011-09-16 B Purchase JOHNSON JOHN

CEO & President

Executive Director
1,500 +100.0%
4.09
US$6,135 		1,500 +100.0% 4.09 US$6,135
2011-09-16 2011-09-16 B Purchase JOHNSON JOHN

CEO & President

Executive Director
25,000 +10.9%
4.10
US$102,492 		25,000 +10.9% 4.10 US$102,492
2011-09-16 2011-09-16 B Purchase YACHMETZ PHILIP K

SVP, General Counsel

Officer
7,000 +3.8%
4.13
US$28,910 		7,000 +3.8% 4.13 US$28,910
2011-09-16 2011-09-15 B Purchase ZUERBLIS KENNETH J

EVP, Chief Financial Officer

Officer
4,000 +400.0%
4.05
US$16,190 		4,000 +400.0% 4.05 US$16,190
2011-09-16 2011-09-15 B Purchase HELLER ALAN L Non-Executive Director
7,500 +23.0%
3.99
US$29,925 		7,500 +23.0% 3.99 US$29,925
2011-09-16 2011-09-14 B Purchase Bahrt Kenneth

SVP, Chief Medical Officer

Officer
500 +1.0%
3.97
US$1,983 		500 +1.0% 3.97 US$1,983
2011-09-16 2011-09-14 B Purchase Bahrt Kenneth

SVP, Chief Medical Officer

Officer
2,500 +5.0%
3.95
US$9,871 		2,500 +5.0% 3.95 US$9,871
2011-09-16 2011-09-14 B Purchase ZUERBLIS KENNETH J

EVP, Chief Financial Officer

Officer
1,000 +inf%
3.97
US$3,970 		1,000 +inf% 3.97 US$3,970
2011-09-16 2011-09-14 B Purchase JOHNSON JOHN

CEO & President

Executive Director
1,500 +inf%
3.88
US$5,824 		1,500 +inf% 3.88 US$5,824
2009-09-15 2009-09-15 S Sale Gionco David

Group VP, CFO

Officer
7,500 -17.3%
15.95
US$119,625 		7,500 -17.3% 15.95 US$119,625
2009-09-15 2009-09-15 S Sale YACHMETZ PHILIP K

SVP, General Counsel

Officer
3,750 -2.1%
16.25
US$60,938 		3,750 -2.1% 16.25 US$60,938
2009-09-15 2009-09-14 S Sale Gionco David

Group VP, CFO

Officer
10,887 -23.3%
15.36
US$167,224 		10,887 -23.3% 15.36 US$167,224
2009-09-15 2009-09-14 S Sale YACHMETZ PHILIP K

SVP, General Counsel

Officer
3,750 -2.0%
15.75
US$59,062 		3,750 -2.0% 15.75 US$59,062
2008-06-26 2008-06-24 PlS Planned sale Hamelin Paul

SVP, Commercial Operations

Officer
1,231 -3.1%
25.25
US$31,083 		1,231 -3.1% 25.25 US$31,083
2008-06-23 2008-06-23 S Sale Hamelin Paul

SVP, Commercial Operations

Officer
5,000 -11.2%
25.75
US$128,751 		5,000 -11.2% 25.75 US$128,751
2008-06-23 2008-06-19 S Sale Hamelin Paul

SVP, Commercial Operations

Officer
1,928 -4.6%
24.89
US$47,994 		1,928 -4.6% 24.89 US$47,994
2008-06-04 2008-06-02 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -38.4%
26.47
US$105,880 		4,000 -38.4% 26.47 US$105,880
2008-05-29 2008-05-27 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -27.7%
24.07
US$96,280 		4,000 -27.7% 24.07 US$96,280
2008-05-21 2008-05-19 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -21.7%
22.67
US$90,680 		4,000 -21.7% 22.67 US$90,680
2008-05-14 2008-05-12 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -19.2%
24.59
US$98,360 		4,000 -19.2% 24.59 US$98,360
2008-05-08 2008-05-06 S Sale HAYDEN BRIAN J

SVP, Chief Financial Officer

Officer
5,000 -25.1%
24.00
US$120,000 		5,000 -25.1% 24.00 US$120,000
2008-05-06 2008-05-06 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -23.9%
24.35
US$121,752 		5,000 -23.9% 24.35 US$121,752
2008-05-05 2008-05-05 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -16.1%
23.90
US$95,600 		4,000 -16.1% 23.90 US$95,600
2008-05-06 2008-05-02 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -23.9%
23.48
US$117,423 		5,000 -23.9% 23.48 US$117,423
2008-05-06 2008-05-02 S Sale Hamelin Paul

SVP, Commercial Operations

Officer
4,750 -10.7%
23.17
US$110,077 		4,750 -10.7% 23.17 US$110,077
2008-05-06 2008-05-02 S Sale HAYDEN BRIAN J

SVP, Chief Financial Officer

Officer
5,000 -20.1%
24.00
US$120,000 		5,000 -20.1% 24.00 US$120,000
2008-05-05 2008-05-01 S Sale KLEIN JOSEPH III Non-Executive Director
4,000 -13.9%
21.71
US$86,840 		4,000 -13.9% 21.71 US$86,840
2008-04-03 2008-04-02 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -23.9%
21.11
US$105,572 		5,000 -23.9% 21.11 US$105,572
2008-04-03 2008-04-01 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -23.9%
21.89
US$109,448 		5,000 -23.9% 21.89 US$109,448
2008-03-05 2008-03-04 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -16.2%
23.00
US$115,000 		5,000 -16.2% 23.00 US$115,000
2008-03-05 2008-03-03 S Sale Hamelin Paul

SVP, Commercial Operations

Officer
2,375 -5.7%
22.78
US$54,102 		2,375 -5.7% 22.78 US$54,102
2008-03-05 2008-03-03 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -16.2%
22.78
US$113,900 		5,000 -16.2% 22.78 US$113,900
2008-03-03 2008-02-29 S Sale HAYDEN BRIAN J

SVP, Chief Financial Officer

Officer
2,279 -11.9%
24.00
US$54,696 		2,279 -11.9% 24.00 US$54,696
2008-03-03 2008-02-28 S Sale HAYDEN BRIAN J

SVP, Chief Financial Officer

Officer
5,000 -20.8%
24.06
US$120,295 		5,000 -20.8% 24.06 US$120,295
2008-02-05 2008-02-04 S Sale HOROWITZ ZEBULUN D

SVP, Chief Medical Officer

Officer
5,000 -3.6%
19.86
US$99,306 		5,000 -3.6% 19.86 US$99,306
2008-02-05 2008-02-04 S Sale CONRAD HERBERT J Non-Executive Director
5,000 -16.2%
20.00
US$100,000 		5,000 -16.2% 20.00 US$100,000
2008-02-05 2008-02-01 S Sale HOROWITZ ZEBULUN D

SVP, Chief Medical Officer

Officer
5,000 -3.6%
19.56
US$97,791 		5,000 -3.6% 19.56 US$97,791
2008-02-05 2008-02-01 S Sale Hamelin Paul

SVP, Commercial Operations

Officer
2,375 -5.4%
20.00
US$47,500 		2,375 -5.4% 20.00 US$47,500
Explore more

More insider trading research around Savient Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America